These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19482838)

  • 1. Valproate-associated coagulopathies in children during short-term treatment.
    Köse G; Arhan E; Unal B; Ozaydin E; Guven A; Sayli TR
    J Child Neurol; 2009 Dec; 24(12):1493-8. PubMed ID: 19482838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
    Koenig S; Gerstner T; Keller A; Teich M; Longin E; Dempfle CE
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombophilic risk factors in epileptic children treated with valproic Acid.
    Unal O; Deda G; Teber S; Ertem M; Akar N
    Pediatr Neurol; 2009 Feb; 40(2):102-6. PubMed ID: 19135623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-associated coagulopathies are frequent and variable in children.
    Gerstner T; Teich M; Bell N; Longin E; Dempfle CE; Brand J; König S
    Epilepsia; 2006 Jul; 47(7):1136-43. PubMed ID: 16886976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro- and anticoagulatory factors under sodium valproate-therapy in children.
    Banerjea MC; Diener W; Kutschke G; Schneble HJ; Korinthenberg R; Sutor AH
    Neuropediatrics; 2002 Aug; 33(4):215-20. PubMed ID: 12368993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate-associated coagulopathies are frequent and variable in children.
    Attilakos A; Katsarou E; Voudris K; Garoufi A
    Epilepsia; 2007 Jan; 48(1):205-6. PubMed ID: 17241231
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of valproate therapy on thrombin generation determined by calibrated automated thrombography.
    Topf HG; Lischetzki G; Trollmann R; Rascher W; Rauh M
    Klin Padiatr; 2011 May; 223(3):165-8. PubMed ID: 21472635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.
    Voudris KA; Attilakos A; Katsarou E; Drakatos A; Dimou S; Mastroyianni S; Skardoutsou A; Prassouli A; Garoufi A
    Epilepsy Res; 2006 Aug; 70(2-3):211-7. PubMed ID: 16781120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein C, protein S and other pro- and anticoagulant activities among epileptic children using sodium valproate.
    Ugras M; Yakinci C
    Brain Dev; 2006 Oct; 28(9):549-53. PubMed ID: 16842952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired von Willebrand syndrome as side effect of valproic acid therapy in children is rare.
    Eberl W; Budde U; Bentele K; Christen HJ; Knapp R; Mey A; Schneppenheim R
    Hamostaseologie; 2009 May; 29(2):137-42. PubMed ID: 19404518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical irrelevance of the hematologic side effects of sodium valproate (Depakine)].
    Loisseau P; Martínez-Lage JM
    Rev Med Univ Navarra; 1981 Sep; 25(3):14-6. PubMed ID: 6803320
    [No Abstract]   [Full Text] [Related]  

  • 12. Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy.
    Attilakos A; Papakonstantinou E; Schulpis K; Voudris K; Katsarou E; Mastroyianni S; Garoufi A
    Epilepsy Res; 2006 Oct; 71(2-3):229-32. PubMed ID: 16889940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis.
    Zighetti ML; Fontana G; Lussana F; Chiesa V; Vignoli A; Canevini MP; Cattaneo M
    Epilepsia; 2015 May; 56(5):e49-52. PubMed ID: 25757394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-drug treatment failures in children newly diagnosed with epilepsy.
    Dudley RW; Penney SJ; Buckley DJ
    Pediatr Neurol; 2009 Feb; 40(2):71-7. PubMed ID: 19135617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of ghrelin in weight gain and growth in epileptic children using valproate.
    Gungor S; Yücel G; Akinci A; Tabel Y; Ozerol IH; Yologlu S
    J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pharmacokinetic observations on valproate: a 3 year follow-up study in 100 children with generalized epilepsy.
    Steinborn B; Galas-Zgorzalewicz B
    Funct Neurol; 1993; 8(6):415-22. PubMed ID: 8150320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate-induced bleeding: report of two cases and review of literature.
    Kumar S
    Indian Pediatr; 2005 Aug; 42(8):833-4. PubMed ID: 16141489
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures.
    Marson AG; Williamson PR; Taylor S; Maguire M; Chadwick DW
    Neurology; 2006 Nov; 67(10):1872-5. PubMed ID: 17130429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective prophylactic therapy for cyclic vomiting syndrome in children using valproate.
    Hikita T; Kodama H; Nakamoto N; Kaga F; Amakata K; Ogita K; Kaneko S; Fujii Y; Yanagawa Y
    Brain Dev; 2009 Jun; 31(6):411-3. PubMed ID: 18752910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between antiepileptic drugs and biological markers affecting long-term cardiovascular function in children and adolescents.
    Cheng LS; Prasad AN; Rieder MJ
    Can J Clin Pharmacol; 2010; 17(1):e5-46. PubMed ID: 20051609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.